Virax Biolabs Group (VRAX) Institutional Ownership $0.86 +0.01 (+0.59%) As of 07/3/2025 01:43 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Virax Biolabs Group (NASDAQ:VRAX)CurrentInstitutional OwnershipPercentage8.61%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$26.69KNumber ofInstitutional Sellers(last 12 months)0 Get VRAX Insider Trade Alerts Want to know when executives and insiders are buying or selling Virax Biolabs Group stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Virax Biolabs Group Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2025XTX Topco Ltd11,863$27K0.0%N/A0.367% 2/13/2024Armistice Capital LLC121,999$178K0.0%N/A7.871% (Data available from 1/1/2016 forward) VRAX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VRAX shares? During the previous two years, the following institutional investors and hedge funds held shares of Virax Biolabs Group shares: Armistice Capital LLC ($178K), XTX Topco Ltd ($27K).Learn more on Virax Biolabs Group's institutional investors. What percentage of Virax Biolabs Group's stock is owned by institutional investors? 8.61% of Virax Biolabs Group's stock is owned by institutional investors. Learn more on VRAX's institutional investor holdings. Which institutional investors have been buying Virax Biolabs Group's stock? The following institutional investors have purchased Virax Biolabs Group's stock in the last 24 months: Armistice Capital LLC ($122.00K), and XTX Topco Ltd ($11.86K). How much institutional buying is happening at Virax Biolabs Group? Institutional investors have bought a total of 11,863 shares in the last 24 months. This purchase volume represents approximately $26.69K in transactions. Related Companies BioCardia Institutional Ownership BioXcel Therapeutics Institutional Ownership Sensei Biotherapeutics Institutional Ownership GlycoMimetics Institutional Ownership Brainstorm Cell Therapeutics Institutional Ownership Cyclerion Therapeutics Institutional Ownership Kiora Pharmaceuticals Institutional Ownership Talphera Institutional Ownership Addex Therapeutics Institutional Ownership Dogwood Therapeutics Institutional Ownership This page (NASDAQ:VRAX) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredJuly 4th: 59% dividend from Bitcoin (No Crypto Needed)I've got something exciting for you this July 4th holiday... How about a 59.07% dividend from Bitcoin? Y...Investors Alley | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virax Biolabs Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Virax Biolabs Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.